| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
| 02/03/2009 | CA2352786C Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 02/03/2009 | CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/29/2009 | WO2009015254A1 Triazine kinase inhibitors |
| 01/29/2009 | WO2009014941A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2008104175A3 Novel phosphodiesterase inhibitors |
| 01/29/2009 | WO2008089453A9 Inhibitors of d-amino acid oxidase |
| 01/29/2009 | US20090030028 Tetrahydroquinolines |
| 01/29/2009 | US20090030025 Trans-fused chromenoisoquinolines synthesis and methods for use |
| 01/29/2009 | US20090030006 sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor; 1,1-anhydro-1-C-[5-(4-ethylphenyl)methyl-2-(hydroxymethyl)phenyl]- beta -D-glucopyranose, for example |
| 01/29/2009 | US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices |
| 01/29/2009 | CA2693377A1 5-pyridinone substituted indazoles |
| 01/28/2009 | EP1470129B1 Radiolabeled neuropeptide y y5 receptor antagonists |
| 01/28/2009 | CN101356161A Heterocyclic CETP inhibitors |
| 01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/28/2009 | CN101353324A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 01/28/2009 | CN100455585C 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 01/27/2009 | US7482452 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
| 01/27/2009 | US7482449 Combining strong base with phenyl isonicotinamide in aprotic solvents to form solution, then reacting with cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482360 Fused tetracyclic mGluR1 antagonists as therapeutic agents |
| 01/27/2009 | US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/27/2009 | US7482338 Non-amide nonanes |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/22/2009 | WO2009011851A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 01/22/2009 | WO2009011655A1 Splropiperidine compounds, a process of their preparation, pharmaceutical compositions containing them, and their use in the treatment of airway diseases, inflammatory diseases, copd or asthma |
| 01/22/2009 | WO2009011654A1 Process for the preparation of cyclic spiropiperidines |
| 01/22/2009 | WO2009011653A1 A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds |
| 01/22/2009 | WO2009011617A2 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 01/22/2009 | WO2009010925A2 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 01/22/2009 | WO2009010824A1 Dihydrochromenopyrazole derivatives as vanilloid receptor ligands |
| 01/22/2009 | WO2009010580A1 Lanthanide (iii) ion complexing compounds, luminescent lanthanide (iii) ion complexes and use thereof as fluorescent labels |
| 01/22/2009 | WO2009010554A1 Process for the enantioselective preparation of pregabalin |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | US20090023927 Process for producing tricyclic ketone |
| 01/22/2009 | US20090023926 Biopolymer ionization; liquid chromatography |
| 01/22/2009 | US20090023748 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
| 01/22/2009 | US20090022689 C4-spiro-pyrrolidine antivirals |
| 01/22/2009 | CA2693904A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | CA2693843A1 Process for the enantioselective preparation of pregabalin |
| 01/22/2009 | CA2693216A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 01/21/2009 | EP2017273A1 Process for the enantioselective preparation of pregabalin |
| 01/21/2009 | EP2016942A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 01/21/2009 | EP2016081A1 Anti-viral pyrimidine nucleoside derivatives |
| 01/21/2009 | EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP1904477B1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 01/21/2009 | CN101351524A Use of rylene derivatives as photosensitizers in solar cells |
| 01/21/2009 | CN101348488A Separation and extraction method for camptothecine |
| 01/21/2009 | CN101347508A Effective component of Sinomenium acutum and preparation and use thereof |
| 01/21/2009 | CN101347468A Effective component of common camptotheca fruit and preparation as well as use thereof |
| 01/21/2009 | CN101347467A Effective component of common camptotheca fruit and preparation as well as use thereof |
| 01/21/2009 | CN100453535C 2-substituted pyrimidines. |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479500 Antidepressant piperidine derivatives of heterocyclefused benzodioxans |
| 01/20/2009 | CA2325526C Aryl phenyl substituted cyclic ketoenols |
| 01/15/2009 | WO2009008405A1 Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor |
| 01/15/2009 | WO2008095912A3 Enantiopure pharmacologically active tricyclic benzimidazoles |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018123 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | CA2688459A1 Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor |
| 01/14/2009 | EP2013213A2 Constrained compounds as cgrp-receptor antagonists |
| 01/14/2009 | EP2013163A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/14/2009 | EP2012778A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 01/14/2009 | EP1560584B1 Fab i inhibitors |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | CN101346471A Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 01/14/2009 | CN101346370A PDF inhibitors |
| 01/14/2009 | CN101343276A Camptothecin derivative and its preparation |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476687 Administering a 1-(2-aminoalkyl)-1H-furo(2,3-g)indazole, e.g.,N-(3-hydroxy-2,2-dimethylpropyl)-1-((S)-2-aminopropyl)-1H-furo[2,3-g]indazole-7-carboxamide; serotonin receptor agonists |
| 01/13/2009 | US7476671 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 01/08/2009 | WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
| 01/08/2009 | WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents |
| 01/08/2009 | WO2008035377A3 Novel intermediates for the preparation of camptothecin analogues |
| 01/08/2009 | US20090012310 reacting polymethine ether compound with an acid to produce polymethine compound containing a desired counter ion |
| 01/08/2009 | US20090012291 Serotonin receptor agonists: 1-(2-aminoalkyl)-1H-furo(2,3-g)indazoles, e.g.,N-(3-hydroxy-2,2-dimethylpropyl)-1-((S)-2-aminopropyl)-1H-furo[2,3-g]indazole-7-carboxamide |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012111 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012081 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090012056 Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor |
| 01/07/2009 | EP2011797A1 Process for production of camptothecin derivative |
| 01/07/2009 | EP2010541A2 Trans-fused chromenoisoquinolines, synthesis and methods for use |
| 01/07/2009 | EP2010540A1 Spiro-imidazo compounds |
| 01/07/2009 | EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials |
| 01/07/2009 | EP2010531A1 Spirocyclic cyclohexane derivative with analgesic properties |
| 01/07/2009 | EP2010515A1 2-(pyridin-2-yl)-pyrimidines for use as fungicides |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |